Skip to main content

Balyasny Asset Management L.P.

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1218710 Chicago, IL

Position in ESPR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
4,654,778
+3925.8% QoQ
Ownership
1.81%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Derivatives in ESPR

reported options exposure · as of Sep 30, 2020
CallValue
$0
CallShares
100,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $126,095,704 across 18 Drug Manufacturers - Specialty & Generic names. ESPR ranks #18 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 4,654,778
2025-09-30 115,624
2024-03-31 159,038
2023-12-31 37,188
2023-06-30 16,039
2023-03-31 4,771,360
2022-12-31 3,429,137
2022-09-30 795,671
2022-06-30 11,971
2020-09-30 100,000
2020-06-30 62,282
2020-03-31 50,000
2020-03-31 261,738